Researchers show how they are using AI to enhance imaging capabilities
Arranged kickbacks in exchange for patient referrals
And what nurses need to do to navigate today’s shifting healthcare paradigm
Incorporates mammogram and EHR data in predictions
Includes TeamPlay, syngo Virtual Cockpit and a number of AI algorithms
Discussed at SNMMI 2019 Annual Meeting
Taking vulnerability out of the online experience
Provides simultaneous 3D cardiac PET perfusion and CFR
Continued growth in use expected through 2019
Bringing a competitive advantage to your hospital
Monitors patients for agonal breathing
Trends that will impact the future of medicine
Equipped with MotionFree to prevent blurring of images
Investments ramp up but challenges remain
Discussing innovations and efforts of SNMMI Technologist Section
An entry into cart-based breast ultrasound market
A few of the solutions you can find on display at the show
Detect up to 33 percent more tumors together
Only for highly-skilled surgeons for now
Using mobile to monitor patients at home can boost care quality — and revenue streams
Suppresses noise and enhances signal for sharper images
Addressing top priorities to reduce administrative burden on providers
Experts from both sides get together and share their views at AAMI
Compound annual growth rate of 20 percent through 2028
Offering 49 million shares at $19 each
Settlement revolved around the 2011 acquisition by IBM of Cúram Software
Could enable dose or infusion rate manipulation
Claims they should no longer exist in a decade
Mobile PET isn't just good medicine, it's good business
May help identify early signs of heart disease
What's new in PET and SPECT?
Aid in advancing quadruple aim
Investment calls for 7.5 billion rubles to bring greater cancer care to patients
Will host new centers and a new imaging department
Found negligent for missing enlarged heart diagnosis in 2009
Expert insights on how project management is evolving
Helps with purchasing, keeping inventory of equipment, end-of-life decisions for devices
Experts weigh in on FDA white paper and ongoing debate
